# OC000459 Bronchial Allergen Challenge

> **NCT01056692** · PHASE2 · COMPLETED · sponsor: **Oxagen Ltd** · enrollment: 20 (actual)

## Conditions studied

- Bronchial Asthma

## Interventions

- **DRUG:** OC000459
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT01056692
- **Lead sponsor:** Oxagen Ltd
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-02
- **Primary completion:** —
- **Final completion:** —
- **Target enrollment:** 20 (ACTUAL)
- **Last updated:** 2010-01-26

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01056692

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01056692, "OC000459 Bronchial Allergen Challenge". Retrieved via AI Analytics 2026-06-05 from https://api.ai-analytics.org/clinical/NCT01056692. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*